drugset
Drugs / Human Rotavirus Vaccine
last change Feb 2013 re-read 3 minutes ago

Human Rotavirus Vaccine

Vaccine

Developed for
Rotavirus infection
Investigated by
Centers for Disease Control and Prevention · GlaxoSmithKline · Navrongo Health Research Centre, Ghana · Noguchi Memorial Institute for Medical Research · PATH

Trials 2

today NCT01575197 · Ph 4 NCT00729001 · Ph 2
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00729001 Nov 2000 → Sep 2002 Rotavirus infection GlaxoSmithKline Completed No outcome recorded
Phase 41 trial · 1 met primary
Phase 4 NCT01575197 Sep 2012 → Feb 2013 Rotavirus infection PATH Completed Met primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Human Rotavirus Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00729001 ↗
1

NCT01575197 ↗
Modality Vaccine “candidate HRV vaccine” NCT00729001 ↗
Route Oral “Two oral doses” NCT00729001 ↗